BANGKOK (The Nation/Asia News Network): Thailand has approved the manufacture of a Covid antibody nasal spray, making it the first in the world.
The spray - jointly developed by Chulalongkorn University, Silpakorn University, the Health Systems Research Institute (HSRI), the Government Pharmaceutical Organisation (GPO) and Hibiocy Co Ltd, an affiliate of Roujukiss International PCL or KISS - was launched at a special event at Samyan Mitrtown Hall on Wednesday (Sept 28).
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
